Harnessing Engineered iPSC-Derived Immuno-Modulatory Alpha Neutrophils for Immune Reconstitution & Cancer Therapy
- Exploring the potential of iPSC-derived alpha neutrophils to restore immune function in oncology and age-related diseases
- Strategies to leverage these cells for robust immune reconstitution following immunosuppressive treatments
- Evaluating therapeutic applications across cancer and chronic inflammation driven by immune decline with age